Approved Pilot and Failed Pivotal Study [Study As­sess­ment]

posted by luvblooms  – India, 2014-03-19 06:16 (4479 d 14:43 ago) – Posting: # 12661
Views: 20,799

Dear Lucas

As per my experience, this is a clear case of Scale-up gone bad (assuming that the Pilot was sone on Lab batch and Pivotal was done on Exhibit batches)

First attempt should be to do some proper in vitro studies to find out the differences between both the batches and then to take a call.

For better understanding could you confirm
a) BCS class of drug (impact of PSD)
b) type of formulation (IR /ER)
c) pH solubility and degradation profile
d) Variations in DT/dissolution observed for both the batches?
e) Any changes in pilot and pivotal study sites?

Regards

~A happy Soul~

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
130 visitors (0 registered, 130 guests [including 37 identified bots]).
Forum time: 22:00 CEST (Europe/Vienna)

Competence, like truth, beauty and contact lenses,
is in the eye of the beholder.    Laurence J. Peter

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5